# EDGAR Filing Document

**Accession Number:** 0001396092
**File Stem:** 0001752724-25-185574
**Filing Date:** 2025-8
**Character Count:** 18439
**Document Hash:** bb03b65f7f447f5fa25cab2be6d32efa
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-25-185574.hdr.sgml**: 20250807

**ACCESSION NUMBER**: 0001752724-25-185574

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250807

**DATE AS OF CHANGE**: 20250807

**PERIOD START**: 20260331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** World Funds Trust
- **CENTRAL INDEX KEY:** 0001396092

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-22172
- **FILM NUMBER:** 251192862

**BUSINESS ADDRESS:**
- **STREET 1:** 8730 STONY POINT PARKWAY
- **STREET 2:** SUITE 205
- **CITY:** RICHMOND
- **STATE:** VA
- **ZIP:** 23235
- **BUSINESS PHONE:** 804-267-7400

**MAIL ADDRESS:**
- **STREET 1:** 8730 STONY POINT PARKWAY
- **STREET 2:** SUITE 205
- **CITY:** RICHMOND
- **STATE:** VA
- **ZIP:** 23235

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Abacus World Funds Trust
- **DATE OF NAME CHANGE:** 20070410

## Series and Classes Contracts Data

### Perkins Discovery Fund (Series ID: S000038882)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000119646 | Investor     | PDFDX           |

## Nport-Ex

**PERKINS DISCOVERY FUND**

**Schedule of Investments**

**June 30, 2025 (unaudited)**

**92.23% COMMON STOCKS**

**17.74% BIOTECHNOLOGY**

**Elutia, Inc.<sup>(A)</sup>**

**MDxHealth SA<sup>(A)</sup>**

**Veracyte, Inc.<sup>(A)</sup>**

**Vericel Corp.<sup>(A)</sup>**

**9.96% CONSUMER DISCRETIONARY**

**Magnite, Inc.<sup>(A)</sup>**

**Perion Network Ltd.<sup>(A)</sup>**

**1.43% FINANCIALS**

**FlexShopper, Inc.<sup>(A)</sup>**

**9.17% HEALTH CARE DRUGS/SERVICES**

**ANI Pharmaceuticals, Inc.<sup>(A)</sup>**

**NeoGenomics, Inc.<sup>(A)</sup>**

**3.92% HEALTH CARE MANUFACTURING**

**AtriCure, Inc.<sup>(A)</sup>**

**14.22% HEALTH CARE SUPPLIES**

**Axogen, Inc.<sup>(A)</sup>**

**BioLife Solutions, Inc.<sup>(A)</sup>**

**Exagen, Inc.<sup>(A)</sup>**

**TELA Bio, Inc.<sup>(A)</sup>**

**9.00% HEALTH CARE SUPPORT**

**Natera, Inc.<sup>(A)</sup>**

**Rockwell Medical, Inc.<sup>(A)</sup>**

---

| | |
|:---|:---|
| **Shares** | **Value** |
| **42500** | $**84150** |
| **32500** | **71825** |
| **16500** | **445995** |
| **12000** | **510600** |
|  | **1112570** |
| **20000** | **482400** |
| **14000** | **142100** |
|  | **624500** |
| **75000** | **90000** |
| **6350** | **414338** |
| **22000** | **160820** |
|  | **575158** |
| **7500** | **245775** |
| **32500** | **352625** |
| **12500** | **269250** |
| **16500** | **115170** |
| **80000** | **155200** |
|  | **892245** |
| **3250** | **549055** |
| **18181** | **15417** |
|  | **564472** |

---

**PERKINS DISCOVERY FUND**

**Schedule of Investments**

**June 30, 2025 (unaudited)**

**5.20% HEALTH CARE TECHNOLOGY**

**Butterfly Network, Inc.<sup>(A)</sup>**

**OptimizeRX Corp.<sup>(A)</sup>**

**Tactile Systems Technology, Inc.<sup>(A)</sup>**

**9.32% INFORMATION TECHNOLOGY**

**Airgain, Inc.<sup>(A)</sup>**

**Digi International, Inc.<sup>(A)</sup>**

**Inuvo, Inc.<sup>(A)</sup>**

**12.27% SOFTWARE SERVICES**

**Asure Software, Inc.<sup>(A)</sup>**

**Backblaze, Inc.<sup>(A)</sup>**

**ePlus, Inc.<sup>(A)</sup>**

**92.23% TOTAL COMMON STOCKS**

**6.24% MONEY MARKET FUND**

**Fidelity Government Portfolio(A) 4.230%<sup>(B)</sup>**

**98.47% TOTAL INVESTMENTS**

**1.55% Other assets, net of liabilities**

**100.00% NET ASSETS**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(A)</sup>Non-income producing

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(B)</sup>Effective 7 day yield as of June 30, 2025

**In accordance with U.S. GAAP, "fair value" is defined as the price that a Fund would receive upon selling an investment in an orderly transaction to an independent buyer in the principal or most advantageous market for the investment. Various inputs are used**

**in determining the value of a Fund's investments. U.S. GAAP established a three-tier hierarchy of inputs to establish a classification of fair value measurements for disclosure purposes. Level 1 includes quoted prices in active markets for identical securities. Level 2 includes other significant observable inputs (including quoted**

---

| | |
|:---|:---|
| **Shares** | **Value** |
| **35500** | $**71000** |
| **14000** | **189000** |
| **6500** | **65910** |
|  | **325910** |
| **14500** | **60175** |
| **9000** | **313740** |
| **45750** | **210450** |
|  | **584365** |
| **25000** | **244000** |
| **30000** | **165000** |
| **5000** | **360500** |
|  | **769500** |
|  | **5784495** |
| **391166** | **391166** |
|  | **6175661** |
|  | **96997** |
|  | $**6272658** |

---

**prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).**

**Level 3 includes significant unobservable inputs (including the Fund's own assumptions in determining fair value of investments).**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **The inputs or methodology used for valuing securities are not necessarily an** | **The inputs or methodology used for valuing securities are not necessarily an** |  |  |  |
| **indication of the risk associated with investing in those securities.** | **indication of the risk associated with investing in those securities.** |  |  |  |
| **The following summarizes the inputs used to value the Fund's investments as of June 30, 2025:** | **The following summarizes the inputs used to value the Fund's investments as of June 30, 2025:** | **The following summarizes the inputs used to value the Fund's investments as of June 30, 2025:** |  |  |
|  | **Level 1** | **Level 2** | **Level 3** |  |
|  |  | **Other** | **Significant** |  |
|  |  | **Significant** | **Unobservable** |  |
|  | **Quoted Prices** | **Observable Inputs** | **Inputs** | **Total** |
| **COMMON STOCKS** | $**5784495.00** | $**-** | $**-** | $**5784495.00** |
| **MONEY MARKET FUND** | $**391166.00** | $**-** | $**-** | $**391166.00** |
| **TOTAL INVESTMENTS** | $**6175661.00** | $**-** | $**-** | $**6175661.00** |
| **The cost of investments for Federal income tax purposes has been estimated a/o June 30, 2025 since** | **The cost of investments for Federal income tax purposes has been estimated a/o June 30, 2025 since** | **The cost of investments for Federal income tax purposes has been estimated a/o June 30, 2025 since** |  |  |
| **the final tax characteristics cannot be determined until fiscal year end. Cost of securities for Federal income** | **the final tax characteristics cannot be determined until fiscal year end. Cost of securities for Federal income** | **the final tax characteristics cannot be determined until fiscal year end. Cost of securities for Federal income** |  |  |
| **tax purpose is $3,856,270, and the related net unrealized appreciation (depreciation) consists of:** | **tax purpose is $3,856,270, and the related net unrealized appreciation (depreciation) consists of:** | **tax purpose is $3,856,270, and the related net unrealized appreciation (depreciation) consists of:** |  |  |
|  |  | **Gross unrealized appreciation** | **Gross unrealized appreciation** | $**3272454** |
|  |  | **Gross unrealized depreciation** | **Gross unrealized depreciation** | **(953063)** |
|  |  | **Net unrealized appreciation** | **Net unrealized appreciation** | $**2319391** |

---

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** World Funds Trust

- **b. Investment Company Act file number:** 811-22172

- **c. CIK number of Registrant:** 0001396092

- **d. LEI of Registrant:** 5493007BOSPYEMKSSY03

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 8730 Stony Point Parkway

  - **City:** Richmond

  - **State:** VA

  - **Foreign country:** US

  - **Zip / Postal Code:** 23235

  - **Telephone number:** 800-673-0550

**Item A.2. Information about the Series.**

- **a. Name of Series:** Perkins Discovery Fund

- **b. EDGAR series identifier (if any):** S000038882

- **c. LEI of Series:** 5493001USSQK1PIP3P25

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-03-31

- **b. Date as of which information is reported:** 2025-06-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $6256868.89

**Total Liabilities:** $15789.21

**Net Assets:** $6272658.10

**Cash Not Reported:** $72221.23

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000119646 | -1.15%               | 1.68%                | 7.07%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $23478.61                | $-83206.77                                 |
| Month 2  | $-71641.90               | $184289.38                                 |
| Month 3  | $298812.53               | $128477.54                                 |

### Schedule of Portfolio Investments

| Name                           | Title                            | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Default                        | OptimizeRX Corp.                 | CUSIP: 68401U204<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14000 | NS      | $189000.00    | 3.01%             |  |  |  | No            |                  1 | On Loan: No      |
| NEOGENOMICS INC                | NeoGenomics, Inc.                | CUSIP: 64049M209<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     22000 | NS      | $160820.00    | 2.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Perion Network Ltd.              | CUSIP: M78673114<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14000 | NS      | $142100.00    | 2.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | BioLife Solutions, Inc.          | CUSIP: 09062W204<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     12500 | NS      | $269250.00    | 4.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Vericel Corp.                  | Vericel Corp.                    | CUSIP: 92346J108<br>LEI: 54930076YM3PLTDR4B91 | Long             | EC               | CORP              | US        |     12000 | NS      | $510600.00    | 8.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | ANI Pharmaceuticals, Inc.        | CUSIP: 00182C103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6350 | NS      | $414337.50    | 6.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Inuvo, Inc.                      | CUSIP: 46122W303<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     45750 | NS      | $210450.00    | 3.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | BUTTERFLY NETWORK INC            | CUSIP: 124155102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     35500 | NS      | $71000.00     | 1.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Elutia Inc                       | CUSIP: 05479K106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     42500 | NS      | $84150.00     | 1.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Rockwell Medical, Inc.           | CUSIP: 774374300<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     18181 | NS      | $15417.49     | 0.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Veracyte, Inc.                   | CUSIP: 92337F107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     16500 | NS      | $445995.00    | 7.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | MDxHealth SA                     | CUSIP: 025927451<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     32500 | NS      | $71825.00     | 1.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Tactile Systems Technology Inc | Tactile Systems Technology, Inc. | CUSIP: 87357P100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6500 | NS      | $65910.00     | 1.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Exagen, Inc.                     | CUSIP: 30068X103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     16500 | NS      | $115170.00    | 1.84%             |  |  |  | No            |                  1 | On Loan: No      |
| ATRICURE INC                   | AtriCure, Inc.                   | CUSIP: 04963C209<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7500 | NS      | $245775.00    | 3.92%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Airgain, Inc.                    | CUSIP: 00938A104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14500 | NS      | $60175.00     | 0.96%             |  |  |  | No            |                  1 | On Loan: No      |
| EPLUS INC                      | EPlus Inc                        | CUSIP: 294268107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5000 | NS      | $360500.00    | 5.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Backblaze Inc                    | CUSIP: 05637B105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     30000 | NS      | $165000.00    | 2.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Fidelity Government Portfolio    | CUSIP: 316175108<br>LEI: N/A                  | Long             | STIV             | RF                | US        |    391166 | NS      | $391165.70    | 6.24%             |  |  |  | No            |                  1 | On Loan: No      |
| AXOGEN INC                     | Axogen, Inc.                     | CUSIP: 05463X106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     32500 | NS      | $352625.00    | 5.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | FlexShopper, Inc.                | CUSIP: 33939J303<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     75000 | NS      | $90000.00     | 1.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Tela Bio Inc                     | CUSIP: 872381108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     80000 | NS      | $155200.00    | 2.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Natera, Inc.                     | CUSIP: 632307104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3250 | NS      | $549055.00    | 8.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Asure Software, Inc.             | CUSIP: 04649U102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     25000 | NS      | $244000.00    | 3.89%             |  |  |  | No            |                  1 | On Loan: No      |
| DIGI INTL INC                  | Digi International, Inc.         | CUSIP: 253798102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      9000 | NS      | $313740.00    | 5.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Default                        | Magnite, Inc.                    | CUSIP: 55955D100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     20000 | NS      | $482400.00    | 7.69%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-08-05

**Name of Applicant:** World Funds Trust

**Signature:** Ann MacDonald

**Name of Signer:** Ann MacDonald

**Title:** Principal Financial Officer